Abstract
The present paper reports the utilization of hybrid nanocomposite particles consisting of PEI25k-PEG5k copolymer grafted silica nanoparticles (SiO2NPs) for enhanced cellular uptake and siRNA delivery. High-resolution transmission electron microscopy and dynamic light scattering measurements ensured the average particle size of the final hybrid component as 45 nm (core SiO2, 28–30 nm and shell PEI25k-PEG5k, 12–15 nm). Surface morphology from atomic force microscopy analysis showed the significant relationship between the particle size and shape. 29Si and 13C cross-polarization–magic angle spinning solid state nuclear magnetic resonance (NMR), 1H-NMR, and Fourier transform infrared spectroscopy were used to obtain the relevant structural information (such as Q3, silanol; Q4, siloxane functional groups of SiO2NPs; resonance shifts and bending vibrations of PEI25k, –CH2–CH2–NH–; and PEG5k, –CH2–CH2–O–) from copolymer nanoparticle. Stable complexation of siRNA and nanocomposite particle (wt.%:wt.%) was achieved from 1:5 to 1:15 ratio. Nanocomposite particle (N/P) ratio and siRNA concentration determine the stability and knockdown efficiency of the PEI25k-PEG5k-graft-SiO2NPs–siRNA complexes. It was shown that highly positively charged (zeta potential, +66 mV) PEI25k-PEG5k-graft-SiO2NPs result in strong affinity with negatively charged siRNA. Confocal microscopy showed intensified cellular uptake of siRNA into cytoplasm of A549 cancer cell utilized for in vitro study. In conclusion, the coherence, graft density of copolymer-SiO2NPs, and siRNA concentration were found to strongly influence the stability, and hence determine the knockdown efficiency, of PEI25k-PEG5k-graft-SiO2NPs–siRNA complexes.
Similar content being viewed by others
References
Ulbrich W, Lamprecht A (2010) J R Soc Interface 7:55–66
Green JJ, Zhou BY, Mitalipova MM, Beard C, Langer R, Jaenisch R (2008) Nano Lett 8:3126–3130
Allouche J, Boissiere M, Helary C, Livage J, Coradin T (2006) J Mater Chem 16:3120–3125
Yu YY, Chen CY, Chen WC (2003) Polymer 44:593–601
Borrego T, Andrade M, Pinto ML, Silva AR, Carvalho AP, Rocha J, Cristina F, Joao P (2010) J Colloid Interf Sci 344:603–610
Kleemann E, Neu M, Jekel N, Fink L, Schmehl T, Gessler T, Seeger W, Kissel T (2005) J Control Release 109:299–316
Burke RS, Pun SH (2008) Bioconjugate Chem 19:693–704
Ashtari P, He X, Wang K, Gong P (2005) Talanta 67:548–554
Jere D, Jiang HL, Arote R, Kim YK, Choi YJ, Cho MH, Akaike T, Cho CS (2009) Expert Opin Drug Deliv 6:827–834
Fuller JE, Zugates GT, Ferreira LS, Ow HS, Nguyen NN, Wiesner UB, Robert SL (2008) Biomaterials 29:1526–1532
Choi SJ, Oh JM, Choy JH (2009) J Inorg Biochem 103:463–471
Wang H, Yang R, Yang L, Tan W (2009) ACS Nano 3:2451–2460
Elbakry A, Zaky A, Liebl R, Rachel R, Goepferich A, Breunig M (2009) Nano Lett 9:2059–2064
Bartlett DW, Su H, Hildebrandt IJ, Weber WA, Davis ME (2007) Proc Natl Acad Sci USA 104:15549–15554
Merkel OM, Livrizzi D, Pfestroff A, Schurrat T, Behe M, Kissel T (2009) Bioconjugate Chem 20:174–182
Christensen LV, Chang CW, Yockman JW, Conners R, Jackson H, Zhong Z, Jan F, David AB, Sung WK (2007) J Control Release 118:254–261
Meade BR, Dowdy SF (2008) Adv Drug Deliv Rev 60:530–536
Yoon TJ, Kim JS, Kim BG, Yu KN, Cho MH, Lee JK (2005) Angew Chem Int Ed 44:1068–1071
Bartlett DW, Davis ME (2008) Biotechnol Bioeng 99:975–985
Akhtar S, Benter IF (2007) J Clin Invest 117:3623–3632
Davis ME (2009) Mol Pharmaceut 6:659–668
Lipski AM, Pino CJ, Haselton FR, Chen IW, Shastri VP (2008) Biomaterials 29:3836–3846
Xu Y, Li Q (2007) Clin Chem 53:1503–1510
Feng L, Wang Y, Wang N, Ma Y (2009) Polym Bull 63:313–327
Joubert M, Delaite C, Bourgeat-Lami B, Dumas P (2005) Macromol Rapid Commun 26:602–607
Estévez MC, O’donoghue MB, Chen X, Tan W (2009) Nano Res 2:448–461
Graf C, Vossen DLJ, Imhof A, Blaaderen AV (2003) Langmuir 19:6693–6700
An Y, Chen M, Xue Q, Liu W (2007) J Colloid Interf Sci 311:507–513
Park KM, Kang HC, Cho JK, Chung IJ, Cho SH, Bae YH, Kun N (2009) Biomaterials 30:2642–2652
Salon MC, Gerbaud G, Abdelmouleh M, Bruzzese C, Boufi S, Belgacem MN (2007) Magn Reson Chem 45:473–483
Brannon-Peppas L, Blanchette JO (2004) Adv Drug Deliv Rev 56:1649–1659
Kobayashi S, Nakase I, Kawabata N, Yu HH, Pujals S, Imanishi M, Ernest G, Shiroh F (2009) Bioconjugate Chem 20:953–959
Lessard-Viger M, Rioux M, Rainville L, Boudreau D (2009) Nano Lett 9(8):3066–3071
Mijatovic WH, Binder HG (2000) Mikrochim Acta 133:175–181
Takayama K, Tadokoro A, Pujals S, Nakase I, Giralt E, Futaki S (2009) Bioconjugate Chem 20:249–257
Mao S, Neu M, Germershaus O, Merkel O, Sitterberg J, Bakowsky U, Thomas K (2006) Bioconjugate Chem 17:1209–1218
Petersen H, Petra MF, Dagmar F, Thomas K (2002) Macromolecules 35:6867–6874
Nguyen HK, Lemieux P, Vinogradov SV, Gebhart CL, Guérin L, Paradis G, Bronich TK, Alakhov VY, Kabanov AV (2000) Gene Ther 7:126–138
Thomas M, Lu JJ, Ge Q, Zhang C, Chen J, Klibanov AM (2005) Proc Natl Acad Sci U S A 102:5679–5684
Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A (2005) Gene Ther 12:461–466
Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, Nel AE, Tamanoi F, Zink JI (2008) ACS Nano 2:889–896
Brus C, Petersen H, Aigner A, Czubayko F, Kissel T (2004) Bioconjugate Chem 15:677–684
Merdan T, Callahan J, Petersen H, Kunath K, Bakowsky U, Kopecková P, Thomas K, Jindřich K (2003) Bioconjugate Chem 14:989–996
Brus C, Petersen H, Aigner A, Czubayko F, Kissel T (2004) Eur J Pharm Biopharm 57:427–430
Glodde M, Sirsi SR, Lutz GJ (2006) Biomacromolecules 7:347–356
Forrest ML, Meister GE, Koerber JT, Pack DW (2004) Pharm Res 21:365–371
Thomas M, Klibanov AM (2002) Proc Natl Acad Sci U S A 99:14640–14645
Doody AM, Korley JN, Dang KP, Zawaneh PN, Putnam D (2006) J Control Release 116:227–237
Petersen H, Fechner PM, Martin AL, Kunath K, Stolnik S, Roberts CJ, Dagmar F, Martyn CD, Thomas K (2002) Bioconjugate Chem 13:845–854
Kunath K, von Harpe A, Petersen H, Fischer D, Voigt K, Kissel T, Ulrich B (2002) Pharm Res 19:810–817
Neu M, Fischer D, Kissel T (2005) J Gene Med 7:992–1009
Duan H, Nie S (2007) J Am Chem Soc 129:3333–3338
Acknowledgements
This study was supported by a grant of the Ministry of Health and Welfare (A040041) and Samsung Biomedical Research Institute, Republic of Korea (PB00021). We thank Ms. Yunhee Kim for solid NMR spectroscopic analysis in NICEM, SNU, and Ms. Youngshin Yoo for HR-TEM analysis in SKKU.
Author information
Authors and Affiliations
Corresponding authors
Additional information
H. Lee and D. Sung contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 313 kb)
Rights and permissions
About this article
Cite this article
Lee, H., Sung, D., Veerapandian, M. et al. PEGylated polyethyleneimine grafted silica nanoparticles: enhanced cellular uptake and efficient siRNA delivery. Anal Bioanal Chem 400, 535–545 (2011). https://doi.org/10.1007/s00216-011-4770-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-011-4770-4